GOODNESS GROWTH HLDGS INC

F:0ZF0 Germany Drug Manufacturers - Specialty & Generic
Market Cap
$40.36 Million
€39.32 Million EUR
Market Cap Rank
#23074 Global
#2515 in Germany
Share Price
€0.35
Change (1 day)
+2.94%
52-Week Range
€0.34 - €0.48
All Time High
€4.50
About

Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly k… Read more

GOODNESS GROWTH HLDGS INC (0ZF0) - Net Assets

Latest net assets as of : €- EUR

Based on the latest financial reports, GOODNESS GROWTH HLDGS INC (0ZF0) has net assets worth €- EUR as of .

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €-
% of Total Assets 0%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility N/A

GOODNESS GROWTH HLDGS INC - Net Assets Trend (None–None)

This chart illustrates how GOODNESS GROWTH HLDGS INC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for GOODNESS GROWTH HLDGS INC (None–None)

The table below shows the annual net assets of GOODNESS GROWTH HLDGS INC from None to None.

Year Net Assets Change
No yearly data available.

Equity Component Analysis

This analysis shows how different components contribute to GOODNESS GROWTH HLDGS INC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • No equity composition insights available.

GOODNESS GROWTH HLDGS INC Competitors by Market Cap

The table below lists competitors of GOODNESS GROWTH HLDGS INC ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in GOODNESS GROWTH HLDGS INC's equity between the two most recent reporting periods.

Insufficient data available to analyze equity growth attribution.

Book Value vs Market Value Analysis

This analysis compares GOODNESS GROWTH HLDGS INC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Insufficient data available to analyze book value vs market value.

Capital Efficiency Dashboard

This dashboard shows how efficiently GOODNESS GROWTH HLDGS INC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Insufficient data available to analyze capital efficiency metrics.

Industry Comparison

This section compares GOODNESS GROWTH HLDGS INC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $9,244,379,027
  • Average return on equity (ROE) among peers: -92.52%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
GOODNESS GROWTH HLDGS INC (0ZF0) €- N/A N/A $33.74 Million
26U (26U) $6.75 Million -514.32% 1.08x $248.33K
27N0 (27N0) $11.56 Million -0.93% 0.00x $4.66K
China Resources Pharmaceutical Group Limited (640) $90.18 Billion 4.60% 1.68x $940.63 Million
CIG WIRELESS (6CW) $27.09 Million -110.19% 3.19x $56.65 Million
Solasia Pharma K.K (9SO) $1.16 Billion -167.91% 0.18x $34.42 Million
Apontis Pharma AG (APPH) $3.46 Million -34.21% 7.59x $11.70 Million
Akebia Therapeutics Inc (AX9) $635.93 Million -22.58% 0.57x $283.56 Million
Biofrontera AG (B8FK) $-12.89 Million 0.00% 0.00x $3.86 Million
AVALA RES (CVJ) $91.87 Million -27.32% 0.11x $113.22K
Deciphera Pharmaceuticals Inc (D05) $341.69 Million -52.37% 0.33x $2.11 Billion